Physician profile
Alexandra Stapleton
NPI 1730824376
$938.38
in general payments reported to CMS, 2019-2025
10 companies · $324 in 2025
The $324 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $325 · 2024: $290 · 2025: $324.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $938.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $344.01 | 2023-2024 | Krystexxa, Repatha, Aimovig |
| Pulmonx Corporation | $162.53 | 2025 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Otsuka America Pharmaceutical, INC. | $122.85 | 2023 | Rexulti |
| Hologic Sales and Service, LLC | $105.52 | 2025 | Aptima |
| Astrazeneca Pharmaceuticals LP | $102.40 | 2024 | Tezspire |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $29.39 | 2025 | Cabtreo |
| Sun Pharmaceutical Industries INC. | $26.07 | 2025 | |
| Merck Sharp & Dohme LLC | $16.66 | 2024 | Vaxelis, Gardasil, Gardasil 9 |
| Paratek Pharmaceuticals, INC. | $15.22 | 2024 | Nuzyra |
| Ironshore Pharmaceuticals INC. | $13.73 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Stapleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.